XML 14 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Current assets    
Cash and cash equivalents $ 678,233 $ 459,453
Accounts receivable, net 1,142,979 938,743
Inventories 834,835 801,100
Prepaid expenses and other current assets 34,860 48,493
Restricted cash 8,626 160,527
Total current assets 2,699,533 2,408,316
Property, plant and equipment, net 6,343,637 6,420,062
Other assets, net    
Goodwill 1,011,342 946,553
Customer relationships, net 635,884 611,615
Other intangible assets, net 166,166 175,839
Deferred charges and other assets, net 387,563 327,868
Total other assets, net 2,200,955 2,061,875
Total assets 11,244,125 10,890,253
Current liabilities    
Accounts payable 560,804 496,259
Accrued liabilities 609,472 537,483
Term loan 0 149,341
Total current liabilities 1,170,276 1,183,083
Long-term debt, net 3,349,402 3,678,654
Deferred income taxes 1,660,914 1,650,575
Pension and other post-retirement benefits 367,705 364,819
Other liabilities 144,329 121,077
Total liabilities 6,692,626 6,998,208
Stockholders' equity    
Preferred stock, $0.01 par value, 50,000,000 shares authorized; no shares issued and outstanding 0 0
Common stock, $0.01 par value, 300,000,000 shares authorized; 134,651,380 and 134,651,380 shares issued at September 30, 2017 and December 31, 2016, respectively 1,347 1,347
Common stock, held in treasury, at cost; 5,551,693 and 5,726,377 shares at September 30, 2017 and December 31, 2016, respectively (314,694) (319,339)
Additional paid-in capital 558,423 550,641
Retained earnings 3,837,644 3,412,286
Accumulated other comprehensive loss (13,946) (121,306)
Total Westlake Chemical Corporation stockholders' equity 4,068,774 3,523,629
Noncontrolling interests 482,725 368,416
Total equity 4,551,499 3,892,045
Total liabilities and equity $ 11,244,125 $ 10,890,253